QIAGEN and Illumina partner to broaden the availability and use of NGS-based in vitro diagnostic (IVD) kits. Read the full press release here.

Introduce our game-changing QIAseq FastSelect –rRNA HMR and –Globin Kits into your RNA-seq workflow and remove >95% of rRNA and globin mRNA from human, mouse, rat and other mammalian samples using just a single 10-second step, with only 14 minutes of incubation. Save even more time with our 30% faster protocol. Request a free trial kit.

At OEM by QIAGEN, we are committed to developing high-quality, customized solutions for your innovative business. You can improve your time to market and make your innovative product a commercial reality. From a specific component to an entire workflow - we offer our expertise as a long-term trusted partner, with full confidentiality, every step of the way.

Despite great progress made by scientists and physicians dedicated to cancer research, a lot of increasingly complex questions remain to be answered to discover new ways to prevent, detect and treat cancer. Visit our new website – advance your cancer research, accelerate your journey to insights and help to conquer cancer.

A new study reinforces the utility of liquid biopsy to identify clinically actionable mutations and guide clinical trial enrollment for patients with advanced cancer. Download your copy of the paper.